id,indicator_code,spatial_dim_type,iso_code,region_code,time_dim_type,region,dim1type,dim1,year,dim2type,dim2,dim3type,dim3,data_source_dim_type,data_source_dim,value,numeric_value,low,high,comments,date,time_dimension_value,time_dimension_begin,time_dimension_end,country,indicator_name,language,title
4263387,AMR_INFECT_MRSA,COUNTRY,MMR,SEAR,YEAR,South-East Asia,NA,NA,2019,NA,NA,NA,NA,NA,NA,55.6,55.61,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Myanmar,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8300227,AMR_INFECT_MRSA,COUNTRY,IND,SEAR,YEAR,South-East Asia,NA,NA,2021,NA,NA,NA,NA,NA,NA,55.7,55.67,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,India,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5096554,AMR_INFECT_MRSA,COUNTRY,KEN,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,44.1,44.12,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Kenya,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7486284,AMR_INFECT_MRSA,COUNTRY,HRV,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,24.9,24.86,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Croatia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3239347,AMR_INFECT_MRSA,COUNTRY,MAR,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,25.8,25.77,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Morocco,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3417761,AMR_INFECT_MRSA,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,6.4,6.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Austria,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4956457,AMR_INFECT_MRSA,COUNTRY,KOR,WPR,YEAR,Western Pacific,NA,NA,2018,NA,NA,NA,NA,NA,NA,47.1,47.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Republic of Korea,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9477473,AMR_INFECT_MRSA,COUNTRY,MWI,AFR,YEAR,Africa,NA,NA,2017,NA,NA,NA,NA,NA,NA,19.7,19.7,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malawi,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1600436,AMR_INFECT_MRSA,COUNTRY,MDG,AFR,YEAR,Africa,NA,NA,2018,NA,NA,NA,NA,NA,NA,18.8,18.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Madagascar,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6533841,AMR_INFECT_MRSA,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,36.4,36.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malta,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7708935,AMR_INFECT_MRSA,COUNTRY,LAO,WPR,YEAR,Western Pacific,NA,NA,2020,NA,NA,NA,NA,NA,NA,22.2,22.22,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Lao People's Democratic Republic,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
859311,AMR_INFECT_MRSA,COUNTRY,MUS,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,39.4,39.36,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Mauritius,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8688331,AMR_INFECT_MRSA,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,10.4,10.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
897697,AMR_INFECT_MRSA,COUNTRY,LTU,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,11.6,11.6,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Lithuania,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1778409,AMR_INFECT_MRSA,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,92.3,92.31,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Egypt,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5242927,AMR_INFECT_MRSA,COUNTRY,YEM,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,93.5,93.46,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Yemen,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1063083,AMR_INFECT_MRSA,COUNTRY,TUR,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,31,30.99,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,TÃ¼rkiye,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7887284,AMR_INFECT_MRSA,COUNTRY,FIN,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,2.1,2.07,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Finland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9821525,AMR_INFECT_MRSA,COUNTRY,UKR,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,15.3,15.28,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Ukraine,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7252235,AMR_INFECT_MRSA,COUNTRY,SYR,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,29.4,29.41,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Syrian Arab Republic,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9732343,AMR_INFECT_MRSA,COUNTRY,LTU,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,8.4,8.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lithuania,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8447066,AMR_INFECT_MRSA,COUNTRY,RUS,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,26.7,26.67,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Russian Federation,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9458818,AMR_INFECT_MRSA,COUNTRY,ZAF,AFR,YEAR,Africa,NA,NA,2018,NA,NA,NA,NA,NA,NA,24.6,24.6,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,South Africa,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3977470,AMR_INFECT_MRSA,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,NA,NA,2019,NA,NA,NA,NA,NA,NA,25,25,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Lebanon,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5878830,AMR_INFECT_MRSA,COUNTRY,ARG,AMR,YEAR,Americas,NA,NA,2021,NA,NA,NA,NA,NA,NA,34.3,34.33,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Argentina,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1829373,AMR_INFECT_MRSA,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,NA,NA,2019,NA,NA,NA,NA,NA,NA,79.6,79.59,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Egypt,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5135331,AMR_INFECT_MRSA,COUNTRY,LAO,WPR,YEAR,Western Pacific,NA,NA,2021,NA,NA,NA,NA,NA,NA,29.9,29.89,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Lao People's Democratic Republic,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8892808,AMR_INFECT_MRSA,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,NA,NA,2019,NA,NA,NA,NA,NA,NA,36.2,36.23,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,United Arab Emirates,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7188818,AMR_INFECT_MRSA,COUNTRY,BRA,AMR,YEAR,Americas,NA,NA,2019,NA,NA,NA,NA,NA,NA,20.6,20.56,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Brazil,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1766215,AMR_INFECT_MRSA,COUNTRY,CHE,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,4.9,4.9,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Switzerland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1848601,AMR_INFECT_MRSA,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,67.1,67.06,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Pakistan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7137828,AMR_INFECT_MRSA,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,12.4,12.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ireland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1082622,AMR_INFECT_MRSA,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,4.9,4.91,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Germany,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2699213,AMR_INFECT_MRSA,COUNTRY,XKX,NA,YEAR,NA,NA,NA,2022,NA,NA,NA,NA,NA,NA,59.3,59.26,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3373781,AMR_INFECT_MRSA,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,32.8,32.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Iran (Islamic Republic of),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5090832,AMR_INFECT_MRSA,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,1.5,1.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8332576,AMR_INFECT_MRSA,COUNTRY,IDN,SEAR,YEAR,South-East Asia,NA,NA,2020,NA,NA,NA,NA,NA,NA,36.2,36.24,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Indonesia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6858547,AMR_INFECT_MRSA,COUNTRY,DNK,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,1.6,1.55,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Denmark,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2775121,AMR_INFECT_MRSA,COUNTRY,CIV,AFR,YEAR,Africa,NA,NA,2020,NA,NA,NA,NA,NA,NA,71.5,71.53,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cote d'Ivoire,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6864951,AMR_INFECT_MRSA,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,41.1,41.08,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Greece,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2438432,AMR_INFECT_MRSA,COUNTRY,CHE,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,4.3,4.34,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Switzerland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3284607,AMR_INFECT_MRSA,COUNTRY,CZE,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,13.2,13.2,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Czechia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5173637,AMR_INFECT_MRSA,COUNTRY,BRA,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,11.1,11.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Brazil,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3793510,AMR_INFECT_MRSA,COUNTRY,IND,SEAR,YEAR,South-East Asia,NA,NA,2020,NA,NA,NA,NA,NA,NA,64.7,64.66,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,India,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7201692,AMR_INFECT_MRSA,COUNTRY,IND,SEAR,YEAR,South-East Asia,NA,NA,2017,NA,NA,NA,NA,NA,NA,52.5,52.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,India,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7271836,AMR_INFECT_MRSA,COUNTRY,BHR,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,42.1,42.11,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Bahrain,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9337893,AMR_INFECT_MRSA,COUNTRY,ISL,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,2.8,2.78,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Iceland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8842022,AMR_INFECT_MRSA,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,3.9,3.89,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9401690,AMR_INFECT_MRSA,COUNTRY,NGA,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,65.1,65.09,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Nigeria,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1391379,AMR_INFECT_MRSA,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,4.6,4.55,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Latvia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4836182,AMR_INFECT_MRSA,COUNTRY,HRV,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,66.7,66.67,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Croatia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6661999,AMR_INFECT_MRSA,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,NA,NA,2019,NA,NA,NA,NA,NA,NA,72.4,72.39,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Jordan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2298452,AMR_INFECT_MRSA,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,NA,NA,2018,NA,NA,NA,NA,NA,NA,47.9,47.9,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Jordan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3048881,AMR_INFECT_MRSA,COUNTRY,LTU,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,9.4,9.42,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Lithuania,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1404187,AMR_INFECT_MRSA,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,12.1,12.08,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,France,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4690946,AMR_INFECT_MRSA,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,35.1,35.09,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Lebanon,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8905914,AMR_INFECT_MRSA,COUNTRY,MUS,AFR,YEAR,Africa,NA,NA,2020,NA,NA,NA,NA,NA,NA,39.6,39.62,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mauritius,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5116617,AMR_INFECT_MRSA,COUNTRY,HRV,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,28.5,28.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Croatia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8670186,AMR_INFECT_MRSA,COUNTRY,PNG,WPR,YEAR,Western Pacific,NA,NA,2022,NA,NA,NA,NA,NA,NA,65.5,65.52,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Papua New Guinea,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4321425,AMR_INFECT_MRSA,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,NA,NA,2018,NA,NA,NA,NA,NA,NA,20,20,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lebanon,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
790292,AMR_INFECT_MRSA,COUNTRY,ARG,AMR,YEAR,Americas,NA,NA,2017,NA,NA,NA,NA,NA,NA,45,45,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Argentina,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5727047,AMR_INFECT_MRSA,COUNTRY,CMR,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,45.5,45.45,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cameroon,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5300924,AMR_INFECT_MRSA,COUNTRY,GEO,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,28.3,28.32,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Georgia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9936499,AMR_INFECT_MRSA,COUNTRY,SOM,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,46.7,46.67,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Somalia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1988987,AMR_INFECT_MRSA,COUNTRY,UKR,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,18.1,18.07,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ukraine,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
542772,AMR_INFECT_MRSA,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,NA,NA,2019,NA,NA,NA,NA,NA,NA,48.9,48.94,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Saudi Arabia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7964327,AMR_INFECT_MRSA,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,2.3,2.33,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sweden,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4868317,AMR_INFECT_MRSA,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,1.5,1.54,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4995727,AMR_INFECT_MRSA,COUNTRY,MDA,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,23.8,23.81,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Republic of Moldova,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4048246,AMR_INFECT_MRSA,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,5.9,5.9,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Austria,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4366213,AMR_INFECT_MRSA,COUNTRY,THA,SEAR,YEAR,South-East Asia,NA,NA,2017,NA,NA,NA,NA,NA,NA,16.7,16.7,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Thailand,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5110448,AMR_INFECT_MRSA,COUNTRY,MDG,AFR,YEAR,Africa,NA,NA,2019,NA,NA,NA,NA,NA,NA,33.3,33.33,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Madagascar,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2147734,AMR_INFECT_MRSA,COUNTRY,AUS,WPR,YEAR,Western Pacific,NA,NA,2021,NA,NA,NA,NA,NA,NA,16.9,16.91,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Australia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2617326,AMR_INFECT_MRSA,COUNTRY,MKD,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,80.8,80.77,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,North Macedonia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2820130,AMR_INFECT_MRSA,COUNTRY,BRA,AMR,YEAR,Americas,NA,NA,2020,NA,NA,NA,NA,NA,NA,24.4,24.41,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Brazil,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1684392,AMR_INFECT_MRSA,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,70.8,70.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Jordan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5758796,AMR_INFECT_MRSA,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,16.3,16.3,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ireland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6770158,AMR_INFECT_MRSA,COUNTRY,SGP,WPR,YEAR,Western Pacific,NA,NA,2019,NA,NA,NA,NA,NA,NA,28.6,28.65,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Singapore,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
402850,AMR_INFECT_MRSA,COUNTRY,ZMB,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,90,90,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Zambia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5595054,AMR_INFECT_MRSA,COUNTRY,KOR,WPR,YEAR,Western Pacific,NA,NA,2017,NA,NA,NA,NA,NA,NA,53.3,53.3,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Republic of Korea,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5320415,AMR_INFECT_MRSA,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,76.3,76.27,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Jordan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
689125,AMR_INFECT_MRSA,COUNTRY,AUS,WPR,YEAR,Western Pacific,NA,NA,2020,NA,NA,NA,NA,NA,NA,17.7,17.65,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Australia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9141229,AMR_INFECT_MRSA,COUNTRY,IND,SEAR,YEAR,South-East Asia,NA,NA,2018,NA,NA,NA,NA,NA,NA,63.1,63.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,India,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4462089,AMR_INFECT_MRSA,COUNTRY,MWI,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,40,40,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Malawi,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6484550,AMR_INFECT_MRSA,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,52,52.05,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Saudi Arabia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5683276,AMR_INFECT_MRSA,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,42.9,42.94,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Cyprus,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2947580,AMR_INFECT_MRSA,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,100,100,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Egypt,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3132485,AMR_INFECT_MRSA,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,14.9,14.94,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Poland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3425619,AMR_INFECT_MRSA,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,12.5,12.52,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,France,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2235897,AMR_INFECT_MRSA,COUNTRY,BEL,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,6.8,6.79,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Belgium,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1340277,AMR_INFECT_MRSA,COUNTRY,LBY,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,70,70,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Libya,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9949793,AMR_INFECT_MRSA,COUNTRY,PHL,WPR,YEAR,Western Pacific,NA,NA,2019,NA,NA,NA,NA,NA,NA,50.9,50.88,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Philippines,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4156984,AMR_INFECT_MRSA,COUNTRY,KEN,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,21.4,21.43,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Kenya,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7627790,AMR_INFECT_MRSA,COUNTRY,CZE,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,9.3,9.33,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Czechia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9020723,AMR_INFECT_MRSA,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,43.3,43.3,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malta,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9052645,AMR_INFECT_MRSA,COUNTRY,RUS,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,7.3,7.28,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Russian Federation,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4691733,AMR_INFECT_MRSA,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,3.8,3.83,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Latvia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2119,AMR_INFECT_MRSA,COUNTRY,BFA,AFR,YEAR,Africa,NA,NA,2020,NA,NA,NA,NA,NA,NA,68.8,68.75,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Burkina Faso,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5130112,AMR_INFECT_MRSA,COUNTRY,CHE,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,5.1,5.12,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Switzerland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8594510,AMR_INFECT_MRSA,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,17.2,17.24,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Tunisia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2535011,AMR_INFECT_MRSA,COUNTRY,MOZ,AFR,YEAR,Africa,NA,NA,2020,NA,NA,NA,NA,NA,NA,25,25,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mozambique,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
505202,AMR_INFECT_MRSA,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,1.2,1.2,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sweden,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3603911,AMR_INFECT_MRSA,COUNTRY,JPN,WPR,YEAR,Western Pacific,NA,NA,2021,NA,NA,NA,NA,NA,NA,35.1,35.05,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Japan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3877306,AMR_INFECT_MRSA,COUNTRY,JPN,WPR,YEAR,Western Pacific,NA,NA,2017,NA,NA,NA,NA,NA,NA,41.7,41.7,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Japan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2324917,AMR_INFECT_MRSA,COUNTRY,ZMB,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,69.4,69.35,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Zambia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2719498,AMR_INFECT_MRSA,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,0.9,0.94,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Norway,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1251236,AMR_INFECT_MRSA,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,NA,NA,2018,NA,NA,NA,NA,NA,NA,46.5,46.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saudi Arabia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8168666,AMR_INFECT_MRSA,COUNTRY,TZA,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,59.5,59.49,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,United Republic of Tanzania,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8225600,AMR_INFECT_MRSA,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,22.1,22.08,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Malta,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
435112,AMR_INFECT_MRSA,COUNTRY,FIN,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,2.2,2.2,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Finland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8938251,AMR_INFECT_MRSA,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,19.9,19.85,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Malta,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9918222,AMR_INFECT_MRSA,COUNTRY,MKD,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,45,45,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,North Macedonia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4106449,AMR_INFECT_MRSA,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,52.5,52.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Lebanon,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2008969,AMR_INFECT_MRSA,COUNTRY,BIH,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,16.3,16.3,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bosnia and Herzegovina,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9237250,AMR_INFECT_MRSA,COUNTRY,FIN,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,2.3,2.31,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Finland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8963900,AMR_INFECT_MRSA,COUNTRY,GEO,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,20.1,20.14,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Georgia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4303522,AMR_INFECT_MRSA,COUNTRY,COD,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,100,100,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Democratic Republic of the Congo,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4271774,AMR_INFECT_MRSA,COUNTRY,FIN,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,1.9,1.9,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Finland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2852705,AMR_INFECT_MRSA,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,37.2,37.21,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Lebanon,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1411686,AMR_INFECT_MRSA,COUNTRY,HRV,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,53.8,53.85,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Croatia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5677493,AMR_INFECT_MRSA,COUNTRY,GEO,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,25.3,25.32,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Georgia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4792958,AMR_INFECT_MRSA,COUNTRY,UGA,AFR,YEAR,Africa,NA,NA,2020,NA,NA,NA,NA,NA,NA,75,75,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Uganda,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6586764,AMR_INFECT_MRSA,COUNTRY,MMR,SEAR,YEAR,South-East Asia,NA,NA,2020,NA,NA,NA,NA,NA,NA,51,50.97,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Myanmar,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5136832,AMR_INFECT_MRSA,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,34,34,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Italy,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2878288,AMR_INFECT_MRSA,COUNTRY,KOR,WPR,YEAR,Western Pacific,NA,NA,2016,NA,NA,NA,NA,NA,NA,53.3,53.3,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Republic of Korea,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4469143,AMR_INFECT_MRSA,COUNTRY,NPL,SEAR,YEAR,South-East Asia,NA,NA,2018,NA,NA,NA,NA,NA,NA,55.6,55.6,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Nepal,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2941805,AMR_INFECT_MRSA,COUNTRY,FIN,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,1.2,1.19,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Finland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1366345,AMR_INFECT_MRSA,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,11,10.96,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Ireland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1786760,AMR_INFECT_MRSA,COUNTRY,FIN,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,1.6,1.63,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Finland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4214880,AMR_INFECT_MRSA,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,41.5,41.46,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Oman,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2700751,AMR_INFECT_MRSA,COUNTRY,LTU,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,8.8,8.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Lithuania,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8467847,AMR_INFECT_MRSA,COUNTRY,KOR,WPR,YEAR,Western Pacific,NA,NA,2021,NA,NA,NA,NA,NA,NA,45.2,45.21,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Republic of Korea,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7850881,AMR_INFECT_MRSA,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,31.2,31.2,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cyprus,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4424669,AMR_INFECT_MRSA,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,34.7,34.71,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Iran (Islamic Republic of),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6478966,AMR_INFECT_MRSA,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,38.4,38.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Greece,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6351014,AMR_INFECT_MRSA,COUNTRY,KHM,WPR,YEAR,Western Pacific,NA,NA,2022,NA,NA,NA,NA,NA,NA,81.3,81.25,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Cambodia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9651644,AMR_INFECT_MRSA,COUNTRY,MUS,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,43,42.96,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mauritius,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9142115,AMR_INFECT_MRSA,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,NA,NA,2017,NA,NA,NA,NA,NA,NA,33.1,33.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saudi Arabia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
531345,AMR_INFECT_MRSA,COUNTRY,KOR,WPR,YEAR,Western Pacific,NA,NA,2022,NA,NA,NA,NA,NA,NA,45.7,45.71,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Republic of Korea,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2268391,AMR_INFECT_MRSA,COUNTRY,TUR,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,31.4,31.35,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,TÃ¼rkiye,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2510184,AMR_INFECT_MRSA,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,28.6,28.57,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Oman,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8048536,AMR_INFECT_MRSA,COUNTRY,CHE,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,3.9,3.91,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Switzerland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6987457,AMR_INFECT_MRSA,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,5.3,5.26,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Austria,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9677249,AMR_INFECT_MRSA,COUNTRY,BRN,WPR,YEAR,Western Pacific,NA,NA,2019,NA,NA,NA,NA,NA,NA,12.3,12.3,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Brunei Darussalam,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8658907,AMR_INFECT_MRSA,COUNTRY,LTU,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,9.8,9.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Lithuania,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4024068,AMR_INFECT_MRSA,COUNTRY,LBR,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,5.9,5.88,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Liberia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2561217,AMR_INFECT_MRSA,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,6.9,6.9,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4939744,AMR_INFECT_MRSA,COUNTRY,SWZ,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,36.4,36.36,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Eswatini,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7692366,AMR_INFECT_MRSA,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,6.8,6.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Germany,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4787021,AMR_INFECT_MRSA,COUNTRY,THA,SEAR,YEAR,South-East Asia,NA,NA,2020,NA,NA,NA,NA,NA,NA,10.6,10.63,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Thailand,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3209900,AMR_INFECT_MRSA,COUNTRY,ETH,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,61.8,61.82,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Ethiopia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4520669,AMR_INFECT_MRSA,COUNTRY,PSE,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,73.3,73.3,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,"occupied Palestinian territory, including east Jerusalem",Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
779083,AMR_INFECT_MRSA,COUNTRY,IDN,SEAR,YEAR,South-East Asia,NA,NA,2022,NA,NA,NA,NA,NA,NA,35.2,35.18,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Indonesia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9034357,AMR_INFECT_MRSA,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,NA,NA,2017,NA,NA,NA,NA,NA,NA,34.1,34.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Arab Emirates,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9231461,AMR_INFECT_MRSA,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,1.6,1.65,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2459556,AMR_INFECT_MRSA,COUNTRY,MLI,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,13.6,13.64,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Mali,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1322249,AMR_INFECT_MRSA,COUNTRY,IRQ,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,86.4,86.36,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Iraq,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6371122,AMR_INFECT_MRSA,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,NA,NA,2019,NA,NA,NA,NA,NA,NA,17.4,17.44,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Tunisia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3356766,AMR_INFECT_MRSA,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,55.9,55.93,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Cyprus,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2022558,AMR_INFECT_MRSA,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,39.9,39.88,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,United Arab Emirates,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1476054,AMR_INFECT_MRSA,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,10.5,10.54,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Ireland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1507502,AMR_INFECT_MRSA,COUNTRY,PSE,EMR,YEAR,Eastern Mediterranean,NA,NA,2019,NA,NA,NA,NA,NA,NA,81.8,81.78,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,"occupied Palestinian territory, including east Jerusalem",Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2408624,AMR_INFECT_MRSA,COUNTRY,AUS,WPR,YEAR,Western Pacific,NA,NA,2019,NA,NA,NA,NA,NA,NA,18.5,18.47,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Australia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8964775,AMR_INFECT_MRSA,COUNTRY,MYS,WPR,YEAR,Western Pacific,NA,NA,2021,NA,NA,NA,NA,NA,NA,16.5,16.45,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Malaysia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9435587,AMR_INFECT_MRSA,COUNTRY,COL,AMR,YEAR,Americas,NA,NA,2021,NA,NA,NA,NA,NA,NA,45.2,45.24,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Colombia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3318582,AMR_INFECT_MRSA,COUNTRY,MKD,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,54.4,54.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,North Macedonia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7775130,AMR_INFECT_MRSA,COUNTRY,XKX,NA,YEAR,NA,NA,NA,2020,NA,NA,NA,NA,NA,NA,64.3,64.29,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1857257,AMR_INFECT_MRSA,COUNTRY,ZAF,AFR,YEAR,Africa,NA,NA,2017,NA,NA,NA,NA,NA,NA,23.8,23.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,South Africa,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2149265,AMR_INFECT_MRSA,COUNTRY,BEN,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,52.6,52.56,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Benin,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9531111,AMR_INFECT_MRSA,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,1.6,1.61,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6473262,AMR_INFECT_MRSA,COUNTRY,ARG,AMR,YEAR,Americas,NA,NA,2018,NA,NA,NA,NA,NA,NA,42.5,42.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Argentina,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3019028,AMR_INFECT_MRSA,COUNTRY,BFA,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,30.4,30.43,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Burkina Faso,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3782975,AMR_INFECT_MRSA,COUNTRY,DNK,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,1.9,1.85,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Denmark,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6123038,AMR_INFECT_MRSA,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,49.5,49.52,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cyprus,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3070169,AMR_INFECT_MRSA,COUNTRY,LBR,AFR,YEAR,Africa,NA,NA,2020,NA,NA,NA,NA,NA,NA,12.9,12.9,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Liberia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1014833,AMR_INFECT_MRSA,COUNTRY,PHL,WPR,YEAR,Western Pacific,NA,NA,2017,NA,NA,NA,NA,NA,NA,58.1,58.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Philippines,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9327342,AMR_INFECT_MRSA,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,1.9,1.9,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sweden,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1558713,AMR_INFECT_MRSA,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,14.7,14.7,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Poland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2332450,AMR_INFECT_MRSA,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,NA,NA,2017,NA,NA,NA,NA,NA,NA,21.6,21.6,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tunisia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5245762,AMR_INFECT_MRSA,COUNTRY,CHE,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,4.1,4.07,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Switzerland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9448616,AMR_INFECT_MRSA,COUNTRY,ZMB,AFR,YEAR,Africa,NA,NA,2020,NA,NA,NA,NA,NA,NA,55,55,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Zambia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2510907,AMR_INFECT_MRSA,COUNTRY,BIH,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,25.8,25.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bosnia and Herzegovina,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7972765,AMR_INFECT_MRSA,COUNTRY,LUX,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,6.2,6.22,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Luxembourg,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5552071,AMR_INFECT_MRSA,COUNTRY,MYS,WPR,YEAR,Western Pacific,NA,NA,2020,NA,NA,NA,NA,NA,NA,17.1,17.12,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Malaysia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4190295,AMR_INFECT_MRSA,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,31.6,31.62,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Qatar,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5843283,AMR_INFECT_MRSA,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,8,7.96,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7115066,AMR_INFECT_MRSA,COUNTRY,RUS,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,14,14,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Russian Federation,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9168413,AMR_INFECT_MRSA,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,1.2,1.2,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5252062,AMR_INFECT_MRSA,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,12.1,12.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,France,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3726320,AMR_INFECT_MRSA,COUNTRY,FIN,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,2,2,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Finland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
169110,AMR_INFECT_MRSA,COUNTRY,CAN,AMR,YEAR,Americas,NA,NA,2022,NA,NA,NA,NA,NA,NA,21,20.98,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Canada,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3707242,AMR_INFECT_MRSA,COUNTRY,UGA,AFR,YEAR,Africa,NA,NA,2017,NA,NA,NA,NA,NA,NA,13,13,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uganda,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2370937,AMR_INFECT_MRSA,COUNTRY,MOZ,AFR,YEAR,Africa,NA,NA,2019,NA,NA,NA,NA,NA,NA,10.3,10.34,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mozambique,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4546969,AMR_INFECT_MRSA,COUNTRY,GHA,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,45.5,45.45,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Ghana,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1730619,AMR_INFECT_MRSA,COUNTRY,HKG,NA,YEAR,NA,NA,NA,2022,NA,NA,NA,NA,NA,NA,45.8,45.84,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,"China, Hong Kong Special Administrative Region",Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3522976,AMR_INFECT_MRSA,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,14,13.99,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ireland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9493541,AMR_INFECT_MRSA,COUNTRY,MYS,WPR,YEAR,Western Pacific,NA,NA,2018,NA,NA,NA,NA,NA,NA,23.1,23.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malaysia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4311247,AMR_INFECT_MRSA,COUNTRY,PER,AMR,YEAR,Americas,NA,NA,2022,NA,NA,NA,NA,NA,NA,49.2,49.15,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Peru,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8049473,AMR_INFECT_MRSA,COUNTRY,KHM,WPR,YEAR,Western Pacific,NA,NA,2020,NA,NA,NA,NA,NA,NA,68.1,68.09,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cambodia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3299961,AMR_INFECT_MRSA,COUNTRY,PHL,WPR,YEAR,Western Pacific,NA,NA,2022,NA,NA,NA,NA,NA,NA,44.4,44.43,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Philippines,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6518012,AMR_INFECT_MRSA,COUNTRY,CZE,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,13.6,13.6,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Czechia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5328743,AMR_INFECT_MRSA,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,NA,NA,2018,NA,NA,NA,NA,NA,NA,23.7,23.7,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Arab Emirates,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5431392,AMR_INFECT_MRSA,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,NA,NA,2017,NA,NA,NA,NA,NA,NA,62.7,62.7,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Pakistan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4005867,AMR_INFECT_MRSA,COUNTRY,LBN,EMR,YEAR,Eastern Mediterranean,NA,NA,2017,NA,NA,NA,NA,NA,NA,8.3,8.3,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Lebanon,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
75786,AMR_INFECT_MRSA,COUNTRY,LKA,SEAR,YEAR,South-East Asia,NA,NA,2020,NA,NA,NA,NA,NA,NA,53.3,53.29,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sri Lanka,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
138140,AMR_INFECT_MRSA,COUNTRY,BHR,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,34.4,34.39,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bahrain,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
183728,AMR_INFECT_MRSA,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,1.7,1.7,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Latvia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
278591,AMR_INFECT_MRSA,COUNTRY,GHA,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,67.9,67.86,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Ghana,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
296714,AMR_INFECT_MRSA,COUNTRY,MDA,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,6.7,6.67,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Republic of Moldova,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
433270,AMR_INFECT_MRSA,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,69.5,69.49,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Pakistan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
559388,AMR_INFECT_MRSA,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,4.4,4.43,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Germany,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
622963,AMR_INFECT_MRSA,COUNTRY,BEL,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,4.6,4.56,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Belgium,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
681416,AMR_INFECT_MRSA,COUNTRY,EST,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,2.3,2.27,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Estonia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
712836,AMR_INFECT_MRSA,COUNTRY,PHL,WPR,YEAR,Western Pacific,NA,NA,2020,NA,NA,NA,NA,NA,NA,45.7,45.69,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Philippines,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
722920,AMR_INFECT_MRSA,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,5.7,5.7,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Latvia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
863144,AMR_INFECT_MRSA,COUNTRY,BEL,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,4.2,4.2,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Belgium,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
964755,AMR_INFECT_MRSA,COUNTRY,SGP,WPR,YEAR,Western Pacific,NA,NA,2022,NA,NA,NA,NA,NA,NA,31.2,31.17,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Singapore,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1061476,AMR_INFECT_MRSA,COUNTRY,THA,SEAR,YEAR,South-East Asia,NA,NA,2019,NA,NA,NA,NA,NA,NA,12.4,12.43,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Thailand,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1075466,AMR_INFECT_MRSA,COUNTRY,LUX,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,7.7,7.7,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Luxembourg,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1111961,AMR_INFECT_MRSA,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,9.1,9.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Germany,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1145372,AMR_INFECT_MRSA,COUNTRY,LKA,SEAR,YEAR,South-East Asia,NA,NA,2022,NA,NA,NA,NA,NA,NA,51.3,51.31,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Sri Lanka,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1191433,AMR_INFECT_MRSA,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,NA,NA,2019,NA,NA,NA,NA,NA,NA,39.1,39.08,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Iran (Islamic Republic of),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1278534,AMR_INFECT_MRSA,COUNTRY,LUX,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,3.1,3.08,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Luxembourg,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1287175,AMR_INFECT_MRSA,COUNTRY,KWT,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,59.1,59.09,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Kuwait,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1361366,AMR_INFECT_MRSA,COUNTRY,MKD,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,100,100,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,North Macedonia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1368615,AMR_INFECT_MRSA,COUNTRY,IDN,SEAR,YEAR,South-East Asia,NA,NA,2021,NA,NA,NA,NA,NA,NA,37.7,37.7,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Indonesia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1376266,AMR_INFECT_MRSA,COUNTRY,THA,SEAR,YEAR,South-East Asia,NA,NA,2022,NA,NA,NA,NA,NA,NA,7.5,7.47,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Thailand,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1389755,AMR_INFECT_MRSA,COUNTRY,IRQ,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,84.6,84.62,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Iraq,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1439778,AMR_INFECT_MRSA,COUNTRY,MLI,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,2.1,2.13,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mali,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1447823,AMR_INFECT_MRSA,COUNTRY,MLI,AFR,YEAR,Africa,NA,NA,2018,NA,NA,NA,NA,NA,NA,0,0,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mali,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1478788,AMR_INFECT_MRSA,COUNTRY,RUS,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,16.5,16.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Russian Federation,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1669311,AMR_INFECT_MRSA,COUNTRY,COD,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,88.5,88.46,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Democratic Republic of the Congo,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1669663,AMR_INFECT_MRSA,COUNTRY,IDN,SEAR,YEAR,South-East Asia,NA,NA,2019,NA,NA,NA,NA,NA,NA,39.9,39.85,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Indonesia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1713222,AMR_INFECT_MRSA,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,42.5,42.52,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United Arab Emirates,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1764919,AMR_INFECT_MRSA,COUNTRY,CZE,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,12.5,12.52,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Czechia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1827351,AMR_INFECT_MRSA,COUNTRY,BIH,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,23.2,23.21,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bosnia and Herzegovina,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1891933,AMR_INFECT_MRSA,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,44.1,44.06,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Iran (Islamic Republic of),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1896986,AMR_INFECT_MRSA,COUNTRY,PHL,WPR,YEAR,Western Pacific,NA,NA,2021,NA,NA,NA,NA,NA,NA,44.6,44.6,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Philippines,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1943459,AMR_INFECT_MRSA,COUNTRY,ZAF,AFR,YEAR,Africa,NA,NA,2019,NA,NA,NA,NA,NA,NA,21.4,21.35,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,South Africa,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1972971,AMR_INFECT_MRSA,COUNTRY,SDN,EMR,YEAR,Eastern Mediterranean,NA,NA,2019,NA,NA,NA,NA,NA,NA,48.4,48.39,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Sudan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
1979434,AMR_INFECT_MRSA,COUNTRY,ARG,AMR,YEAR,Americas,NA,NA,2022,NA,NA,NA,NA,NA,NA,32.8,32.79,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Argentina,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2030936,AMR_INFECT_MRSA,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,41.2,41.16,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Greece,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2057322,AMR_INFECT_MRSA,COUNTRY,BGD,SEAR,YEAR,South-East Asia,NA,NA,2022,NA,NA,NA,NA,NA,NA,88.5,88.46,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Bangladesh,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2062378,AMR_INFECT_MRSA,COUNTRY,RUS,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,17,17.04,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Russian Federation,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2082367,AMR_INFECT_MRSA,COUNTRY,MKD,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,48.5,48.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,North Macedonia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2086974,AMR_INFECT_MRSA,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,31.8,31.82,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Oman,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2093675,AMR_INFECT_MRSA,COUNTRY,BRA,AMR,YEAR,Americas,NA,NA,2022,NA,NA,NA,NA,NA,NA,31.6,31.58,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Brazil,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2169168,AMR_INFECT_MRSA,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,13.6,13.64,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Latvia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2170258,AMR_INFECT_MRSA,COUNTRY,PER,AMR,YEAR,Americas,NA,NA,2020,NA,NA,NA,NA,NA,NA,47.1,47.06,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Peru,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2189165,AMR_INFECT_MRSA,COUNTRY,THA,SEAR,YEAR,South-East Asia,NA,NA,2021,NA,NA,NA,NA,NA,NA,7.6,7.61,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Thailand,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2346820,AMR_INFECT_MRSA,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,6.7,6.74,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2391682,AMR_INFECT_MRSA,COUNTRY,AUS,WPR,YEAR,Western Pacific,NA,NA,2022,NA,NA,NA,NA,NA,NA,15,14.97,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Australia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2670537,AMR_INFECT_MRSA,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,2,2,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Latvia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2677032,AMR_INFECT_MRSA,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,32.1,32.05,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Qatar,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2778180,AMR_INFECT_MRSA,COUNTRY,IDN,SEAR,YEAR,South-East Asia,NA,NA,2018,NA,NA,NA,NA,NA,NA,52.3,52.3,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Indonesia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2780136,AMR_INFECT_MRSA,COUNTRY,MOZ,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,25,25,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Mozambique,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
2932607,AMR_INFECT_MRSA,COUNTRY,MOZ,AFR,YEAR,Africa,NA,NA,2018,NA,NA,NA,NA,NA,NA,20,20,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mozambique,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3110574,AMR_INFECT_MRSA,COUNTRY,TLS,SEAR,YEAR,South-East Asia,NA,NA,2021,NA,NA,NA,NA,NA,NA,37.5,37.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Timor-Leste,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3188191,AMR_INFECT_MRSA,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,40.2,40.2,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cyprus,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3199970,AMR_INFECT_MRSA,COUNTRY,CHE,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,4.7,4.7,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Switzerland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3249906,AMR_INFECT_MRSA,COUNTRY,CZE,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,7.6,7.64,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Czechia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3283698,AMR_INFECT_MRSA,COUNTRY,GBR,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,7.3,7.3,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3452969,AMR_INFECT_MRSA,COUNTRY,SGP,WPR,YEAR,Western Pacific,NA,NA,2021,NA,NA,NA,NA,NA,NA,32.5,32.54,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Singapore,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3479975,AMR_INFECT_MRSA,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,3.9,3.87,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Austria,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3491273,AMR_INFECT_MRSA,COUNTRY,ETH,AFR,YEAR,Africa,NA,NA,2020,NA,NA,NA,NA,NA,NA,39.3,39.29,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ethiopia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3498059,AMR_INFECT_MRSA,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,1.1,1.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Norway,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3543148,AMR_INFECT_MRSA,COUNTRY,GEO,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,12.5,12.52,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Georgia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3580693,AMR_INFECT_MRSA,COUNTRY,PHL,WPR,YEAR,Western Pacific,NA,NA,2016,NA,NA,NA,NA,NA,NA,66.1,66.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Philippines,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3601201,AMR_INFECT_MRSA,COUNTRY,KHM,WPR,YEAR,Western Pacific,NA,NA,2018,NA,NA,NA,NA,NA,NA,48.8,48.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cambodia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3657988,AMR_INFECT_MRSA,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,1.8,1.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sweden,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3715297,AMR_INFECT_MRSA,COUNTRY,IRN,EMR,YEAR,Eastern Mediterranean,NA,NA,2018,NA,NA,NA,NA,NA,NA,38.5,38.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iran (Islamic Republic of),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3828923,AMR_INFECT_MRSA,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,50.4,50.38,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Saudi Arabia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3886587,AMR_INFECT_MRSA,COUNTRY,MKD,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,53.5,53.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,North Macedonia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3906411,AMR_INFECT_MRSA,COUNTRY,BRN,WPR,YEAR,Western Pacific,NA,NA,2022,NA,NA,NA,NA,NA,NA,12.2,12.16,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Brunei Darussalam,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3974991,AMR_INFECT_MRSA,COUNTRY,MWI,AFR,YEAR,Africa,NA,NA,2016,NA,NA,NA,NA,NA,NA,82,82,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malawi,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
3981361,AMR_INFECT_MRSA,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,30.9,30.88,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Italy,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4110564,AMR_INFECT_MRSA,COUNTRY,NPL,SEAR,YEAR,South-East Asia,NA,NA,2022,NA,NA,NA,NA,NA,NA,83.3,83.33,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Nepal,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4254442,AMR_INFECT_MRSA,COUNTRY,HRV,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,26.4,26.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Croatia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4305980,AMR_INFECT_MRSA,COUNTRY,MLI,AFR,YEAR,Africa,NA,NA,2019,NA,NA,NA,NA,NA,NA,2.5,2.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Mali,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4345847,AMR_INFECT_MRSA,COUNTRY,TLS,SEAR,YEAR,South-East Asia,NA,NA,2020,NA,NA,NA,NA,NA,NA,21.4,21.43,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Timor-Leste,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4408151,AMR_INFECT_MRSA,COUNTRY,LUX,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,9.5,9.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Luxembourg,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4511250,AMR_INFECT_MRSA,COUNTRY,MMR,SEAR,YEAR,South-East Asia,NA,NA,2022,NA,NA,NA,NA,NA,NA,66.7,66.67,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Myanmar,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4535564,AMR_INFECT_MRSA,COUNTRY,PER,AMR,YEAR,Americas,NA,NA,2021,NA,NA,NA,NA,NA,NA,81.5,81.54,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Peru,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4556316,AMR_INFECT_MRSA,COUNTRY,BIH,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,18,18,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Bosnia and Herzegovina,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4619214,AMR_INFECT_MRSA,COUNTRY,BHR,EMR,YEAR,Eastern Mediterranean,NA,NA,2019,NA,NA,NA,NA,NA,NA,40,40,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bahrain,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4689082,AMR_INFECT_MRSA,COUNTRY,XKX,NA,YEAR,NA,NA,NA,2021,NA,NA,NA,NA,NA,NA,43.8,43.75,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4790706,AMR_INFECT_MRSA,COUNTRY,GEO,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,11.6,11.6,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Georgia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4833186,AMR_INFECT_MRSA,COUNTRY,NPL,SEAR,YEAR,South-East Asia,NA,NA,2020,NA,NA,NA,NA,NA,NA,79,79.01,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Nepal,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4871481,AMR_INFECT_MRSA,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,49.1,49.09,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Saudi Arabia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
4916952,AMR_INFECT_MRSA,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,3.1,3.12,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Austria,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5032144,AMR_INFECT_MRSA,COUNTRY,BTN,SEAR,YEAR,South-East Asia,NA,NA,2019,NA,NA,NA,NA,NA,NA,20.8,20.79,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bhutan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5032797,AMR_INFECT_MRSA,COUNTRY,LAO,WPR,YEAR,Western Pacific,NA,NA,2018,NA,NA,NA,NA,NA,NA,11.4,11.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lao People's Democratic Republic,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5120308,AMR_INFECT_MRSA,COUNTRY,MDG,AFR,YEAR,Africa,NA,NA,2017,NA,NA,NA,NA,NA,NA,30,30,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Madagascar,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5120653,AMR_INFECT_MRSA,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,12.9,12.9,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,France,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5122014,AMR_INFECT_MRSA,COUNTRY,PHL,WPR,YEAR,Western Pacific,NA,NA,2018,NA,NA,NA,NA,NA,NA,55.4,55.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Philippines,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5132688,AMR_INFECT_MRSA,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,82.6,82.56,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Pakistan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5227994,AMR_INFECT_MRSA,COUNTRY,LTU,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,9,8.98,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Lithuania,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5292911,AMR_INFECT_MRSA,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,NA,NA,2018,NA,NA,NA,NA,NA,NA,28.6,28.6,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Pakistan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5386743,AMR_INFECT_MRSA,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,15.2,15.2,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Poland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5394879,AMR_INFECT_MRSA,COUNTRY,SDN,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,35.7,35.71,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Sudan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5426523,AMR_INFECT_MRSA,COUNTRY,LAO,WPR,YEAR,Western Pacific,NA,NA,2017,NA,NA,NA,NA,NA,NA,9.5,9.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Lao People's Democratic Republic,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5447004,AMR_INFECT_MRSA,COUNTRY,LUX,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,4.7,4.68,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Luxembourg,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5471346,AMR_INFECT_MRSA,COUNTRY,MOZ,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,6.7,6.67,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Mozambique,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5507932,AMR_INFECT_MRSA,COUNTRY,CZE,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,9.4,9.43,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Czechia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5578987,AMR_INFECT_MRSA,COUNTRY,UKR,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,28,28.05,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Ukraine,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5623522,AMR_INFECT_MRSA,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,NA,NA,2018,NA,NA,NA,NA,NA,NA,21.1,21.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Tunisia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5742569,AMR_INFECT_MRSA,COUNTRY,LAO,WPR,YEAR,Western Pacific,NA,NA,2022,NA,NA,NA,NA,NA,NA,55.9,55.88,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Lao People's Democratic Republic,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5756113,AMR_INFECT_MRSA,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,20.4,20.39,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Malta,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5780164,AMR_INFECT_MRSA,COUNTRY,ZAF,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,16.6,16.64,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,South Africa,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
5990456,AMR_INFECT_MRSA,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,30.6,30.6,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Italy,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6042212,AMR_INFECT_MRSA,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,11,11,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,France,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6119325,AMR_INFECT_MRSA,COUNTRY,PSE,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,89.5,89.49,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,"occupied Palestinian territory, including east Jerusalem",Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6137399,AMR_INFECT_MRSA,COUNTRY,JPN,WPR,YEAR,Western Pacific,NA,NA,2020,NA,NA,NA,NA,NA,NA,35.9,35.86,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Japan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6257424,AMR_INFECT_MRSA,COUNTRY,EST,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,3.1,3.09,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Estonia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6270833,AMR_INFECT_MRSA,COUNTRY,BFA,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,51.2,51.16,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Burkina Faso,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6341704,AMR_INFECT_MRSA,COUNTRY,MWI,AFR,YEAR,Africa,NA,NA,2020,NA,NA,NA,NA,NA,NA,61.2,61.19,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Malawi,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6391856,AMR_INFECT_MRSA,COUNTRY,HRV,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,50,50,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Croatia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6543780,AMR_INFECT_MRSA,COUNTRY,JOR,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,58.4,58.39,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Jordan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6570056,AMR_INFECT_MRSA,COUNTRY,FRA,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,11.2,11.15,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,France,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6595859,AMR_INFECT_MRSA,COUNTRY,THA,SEAR,YEAR,South-East Asia,NA,NA,2018,NA,NA,NA,NA,NA,NA,11.3,11.3,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Thailand,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6633417,AMR_INFECT_MRSA,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,NA,NA,2018,NA,NA,NA,NA,NA,NA,50,50,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Oman,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6659458,AMR_INFECT_MRSA,COUNTRY,DNK,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,1.9,1.94,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Denmark,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6660810,AMR_INFECT_MRSA,COUNTRY,ZAF,AFR,YEAR,Africa,NA,NA,2016,NA,NA,NA,NA,NA,NA,24.9,24.9,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,South Africa,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6677362,AMR_INFECT_MRSA,COUNTRY,AUT,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,4.5,4.47,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Austria,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6691461,AMR_INFECT_MRSA,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,30.1,30.06,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Qatar,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6709475,AMR_INFECT_MRSA,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,69.4,69.44,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Egypt,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6811259,AMR_INFECT_MRSA,COUNTRY,EGY,EMR,YEAR,Eastern Mediterranean,NA,NA,2018,NA,NA,NA,NA,NA,NA,70.4,70.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Egypt,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6818143,AMR_INFECT_MRSA,COUNTRY,MAR,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,23.6,23.58,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Morocco,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6842208,AMR_INFECT_MRSA,COUNTRY,CYP,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,100,100,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Cyprus,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6900269,AMR_INFECT_MRSA,COUNTRY,BHR,EMR,YEAR,Eastern Mediterranean,NA,NA,2018,NA,NA,NA,NA,NA,NA,35.5,35.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bahrain,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
6957334,AMR_INFECT_MRSA,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,36.4,36.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Greece,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7015770,AMR_INFECT_MRSA,COUNTRY,KOR,WPR,YEAR,Western Pacific,NA,NA,2019,NA,NA,NA,NA,NA,NA,48.6,48.61,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Republic of Korea,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7097386,AMR_INFECT_MRSA,COUNTRY,NGA,AFR,YEAR,Africa,NA,NA,2018,NA,NA,NA,NA,NA,NA,65.8,65.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Nigeria,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7103383,AMR_INFECT_MRSA,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,NA,NA,2019,NA,NA,NA,NA,NA,NA,65,64.98,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Pakistan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7109640,AMR_INFECT_MRSA,COUNTRY,ARG,AMR,YEAR,Americas,NA,NA,2019,NA,NA,NA,NA,NA,NA,42,42.03,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Argentina,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7122873,AMR_INFECT_MRSA,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,13.7,13.66,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Poland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7123165,AMR_INFECT_MRSA,COUNTRY,ZAF,AFR,YEAR,Africa,NA,NA,2020,NA,NA,NA,NA,NA,NA,19.6,19.64,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,South Africa,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7147470,AMR_INFECT_MRSA,COUNTRY,LVA,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,12.3,12.28,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Latvia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7153880,AMR_INFECT_MRSA,COUNTRY,LKA,SEAR,YEAR,South-East Asia,NA,NA,2021,NA,NA,NA,NA,NA,NA,47.2,47.21,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Sri Lanka,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7187964,AMR_INFECT_MRSA,COUNTRY,QAT,EMR,YEAR,Eastern Mediterranean,NA,NA,2019,NA,NA,NA,NA,NA,NA,33.8,33.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Qatar,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7250873,AMR_INFECT_MRSA,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,36.5,36.55,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Italy,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7275044,AMR_INFECT_MRSA,COUNTRY,JPN,WPR,YEAR,Western Pacific,NA,NA,2018,NA,NA,NA,NA,NA,NA,40.6,40.6,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Japan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7327438,AMR_INFECT_MRSA,COUNTRY,NPL,SEAR,YEAR,South-East Asia,NA,NA,2021,NA,NA,NA,NA,NA,NA,57.9,57.89,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Nepal,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7339385,AMR_INFECT_MRSA,COUNTRY,BRN,WPR,YEAR,Western Pacific,NA,NA,2020,NA,NA,NA,NA,NA,NA,12.5,12.47,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Brunei Darussalam,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7344601,AMR_INFECT_MRSA,COUNTRY,MMR,SEAR,YEAR,South-East Asia,NA,NA,2018,NA,NA,NA,NA,NA,NA,74.1,74.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Myanmar,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7353224,AMR_INFECT_MRSA,COUNTRY,NGA,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,66.7,66.67,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Nigeria,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7371535,AMR_INFECT_MRSA,COUNTRY,ZAF,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,16.5,16.48,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,South Africa,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7376026,AMR_INFECT_MRSA,COUNTRY,JPN,WPR,YEAR,Western Pacific,NA,NA,2019,NA,NA,NA,NA,NA,NA,36.4,36.42,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Japan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7389838,AMR_INFECT_MRSA,COUNTRY,MLT,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,19.6,19.57,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Malta,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7402937,AMR_INFECT_MRSA,COUNTRY,LUX,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,5.5,5.53,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Luxembourg,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7408925,AMR_INFECT_MRSA,COUNTRY,MKD,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,53.8,53.85,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,North Macedonia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7427736,AMR_INFECT_MRSA,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,1.9,1.85,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Sweden,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7523561,AMR_INFECT_MRSA,COUNTRY,OMN,EMR,YEAR,Eastern Mediterranean,NA,NA,2017,NA,NA,NA,NA,NA,NA,41.1,41.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Oman,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7535400,AMR_INFECT_MRSA,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,43.2,43.18,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Greece,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7568755,AMR_INFECT_MRSA,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,16.5,16.52,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Poland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7573478,AMR_INFECT_MRSA,COUNTRY,COL,AMR,YEAR,Americas,NA,NA,2022,NA,NA,NA,NA,NA,NA,45.2,45.15,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Colombia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7592861,AMR_INFECT_MRSA,COUNTRY,IRL,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,15,14.96,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Ireland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7618409,AMR_INFECT_MRSA,COUNTRY,THA,SEAR,YEAR,South-East Asia,NA,NA,2016,NA,NA,NA,NA,NA,NA,13.4,13.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Thailand,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7814194,AMR_INFECT_MRSA,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,1.3,1.27,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Norway,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7879531,AMR_INFECT_MRSA,COUNTRY,IRQ,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,87.8,87.76,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Iraq,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7929101,AMR_INFECT_MRSA,COUNTRY,MLI,AFR,YEAR,Africa,NA,NA,2020,NA,NA,NA,NA,NA,NA,10.4,10.42,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mali,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7930856,AMR_INFECT_MRSA,COUNTRY,TZA,AFR,YEAR,Africa,NA,NA,2020,NA,NA,NA,NA,NA,NA,50.2,50.21,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United Republic of Tanzania,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7941668,AMR_INFECT_MRSA,COUNTRY,LTU,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,9.3,9.3,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Lithuania,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7948458,AMR_INFECT_MRSA,COUNTRY,TZA,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,64.9,64.88,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,United Republic of Tanzania,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
7981117,AMR_INFECT_MRSA,COUNTRY,ETH,AFR,YEAR,Africa,NA,NA,2021,NA,NA,NA,NA,NA,NA,59.2,59.23,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Ethiopia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8043230,AMR_INFECT_MRSA,COUNTRY,GEO,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,4.2,4.2,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Georgia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8051347,AMR_INFECT_MRSA,COUNTRY,POL,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,15.9,15.9,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Poland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8145873,AMR_INFECT_MRSA,COUNTRY,NGA,AFR,YEAR,Africa,NA,NA,2017,NA,NA,NA,NA,NA,NA,62.8,62.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Nigeria,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8299824,AMR_INFECT_MRSA,COUNTRY,KWT,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,43.5,43.55,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kuwait,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8318127,AMR_INFECT_MRSA,COUNTRY,BIH,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,10.6,10.55,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Bosnia and Herzegovina,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8350020,AMR_INFECT_MRSA,COUNTRY,SDN,EMR,YEAR,Eastern Mediterranean,NA,NA,2018,NA,NA,NA,NA,NA,NA,52.2,52.2,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sudan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8443989,AMR_INFECT_MRSA,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,12.1,12.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Tunisia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8464919,AMR_INFECT_MRSA,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,7.6,7.6,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Germany,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8501858,AMR_INFECT_MRSA,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,NA,NA,2022,NA,NA,NA,NA,NA,NA,13.6,13.61,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Tunisia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8502014,AMR_INFECT_MRSA,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,2,1.97,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Sweden,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8522298,AMR_INFECT_MRSA,COUNTRY,CHE,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,5.8,5.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Switzerland,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8559180,AMR_INFECT_MRSA,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2017,NA,NA,NA,NA,NA,NA,1,1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Norway,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8586211,AMR_INFECT_MRSA,COUNTRY,GRC,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,43.4,43.41,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Greece,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8603247,AMR_INFECT_MRSA,COUNTRY,ARG,AMR,YEAR,Americas,NA,NA,2020,NA,NA,NA,NA,NA,NA,38.4,38.4,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Argentina,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8605122,AMR_INFECT_MRSA,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,5.6,5.58,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Germany,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8764518,AMR_INFECT_MRSA,COUNTRY,BTN,SEAR,YEAR,South-East Asia,NA,NA,2020,NA,NA,NA,NA,NA,NA,11.7,11.67,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bhutan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8769113,AMR_INFECT_MRSA,COUNTRY,IND,SEAR,YEAR,South-East Asia,NA,NA,2019,NA,NA,NA,NA,NA,NA,60.6,60.61,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,India,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8948185,AMR_INFECT_MRSA,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,2,2.01,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Norway,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8959991,AMR_INFECT_MRSA,COUNTRY,LKA,SEAR,YEAR,South-East Asia,NA,NA,2019,NA,NA,NA,NA,NA,NA,56,55.99,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Sri Lanka,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8960596,AMR_INFECT_MRSA,COUNTRY,CMR,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,76,76,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Cameroon,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8992882,AMR_INFECT_MRSA,COUNTRY,JPN,WPR,YEAR,Western Pacific,NA,NA,2022,NA,NA,NA,NA,NA,NA,33.9,33.89,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Japan,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
8993204,AMR_INFECT_MRSA,COUNTRY,BRA,AMR,YEAR,Americas,NA,NA,2021,NA,NA,NA,NA,NA,NA,7,7,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Brazil,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9025098,AMR_INFECT_MRSA,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,NA,NA,2016,NA,NA,NA,NA,NA,NA,24.5,24.5,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Tunisia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9031118,AMR_INFECT_MRSA,COUNTRY,BIH,EUR,YEAR,Europe,NA,NA,2021,NA,NA,NA,NA,NA,NA,20.8,20.83,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Bosnia and Herzegovina,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9106183,AMR_INFECT_MRSA,COUNTRY,DEU,EUR,YEAR,Europe,NA,NA,2016,NA,NA,NA,NA,NA,NA,10.3,10.3,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Germany,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9119769,AMR_INFECT_MRSA,COUNTRY,LAO,WPR,YEAR,Western Pacific,NA,NA,2019,NA,NA,NA,NA,NA,NA,6.1,6.06,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Lao People's Democratic Republic,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9182176,AMR_INFECT_MRSA,COUNTRY,NAM,AFR,YEAR,Africa,NA,NA,2022,NA,NA,NA,NA,NA,NA,0,0,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Namibia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9245390,AMR_INFECT_MRSA,COUNTRY,NGA,AFR,YEAR,Africa,NA,NA,2020,NA,NA,NA,NA,NA,NA,75.4,75.41,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Nigeria,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9379607,AMR_INFECT_MRSA,COUNTRY,SWE,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,1.8,1.8,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Sweden,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9417106,AMR_INFECT_MRSA,COUNTRY,NLD,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,2.3,2.31,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9424463,AMR_INFECT_MRSA,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,NA,NA,2021,NA,NA,NA,NA,NA,NA,35.7,35.65,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,United Arab Emirates,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9432588,AMR_INFECT_MRSA,COUNTRY,DJI,EMR,YEAR,Eastern Mediterranean,NA,NA,2020,NA,NA,NA,NA,NA,NA,0,0,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Djibouti,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9501864,AMR_INFECT_MRSA,COUNTRY,MYS,WPR,YEAR,Western Pacific,NA,NA,2017,NA,NA,NA,NA,NA,NA,21.9,21.9,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malaysia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9514164,AMR_INFECT_MRSA,COUNTRY,MYS,WPR,YEAR,Western Pacific,NA,NA,2019,NA,NA,NA,NA,NA,NA,19.5,19.53,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Malaysia,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9521487,AMR_INFECT_MRSA,COUNTRY,BIH,EUR,YEAR,Europe,NA,NA,2022,NA,NA,NA,NA,NA,NA,26.5,26.51,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Bosnia and Herzegovina,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9528165,AMR_INFECT_MRSA,COUNTRY,ITA,EUR,YEAR,Europe,NA,NA,2019,NA,NA,NA,NA,NA,NA,38.8,38.75,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Italy,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9603694,AMR_INFECT_MRSA,COUNTRY,BRN,WPR,YEAR,Western Pacific,NA,NA,2021,NA,NA,NA,NA,NA,NA,14.6,14.62,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2021,2021-01-01T00:00:00+01:00,2021-12-31T00:00:00+01:00,Brunei Darussalam,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9667792,AMR_INFECT_MRSA,COUNTRY,IND,SEAR,YEAR,South-East Asia,NA,NA,2022,NA,NA,NA,NA,NA,NA,54.9,54.85,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,India,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9742440,AMR_INFECT_MRSA,COUNTRY,RUS,EUR,YEAR,Europe,NA,NA,2020,NA,NA,NA,NA,NA,NA,28.9,28.89,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Russian Federation,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9820495,AMR_INFECT_MRSA,COUNTRY,NOR,EUR,YEAR,Europe,NA,NA,2018,NA,NA,NA,NA,NA,NA,0.9,0.9,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Norway,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9894818,AMR_INFECT_MRSA,COUNTRY,TLS,SEAR,YEAR,South-East Asia,NA,NA,2022,NA,NA,NA,NA,NA,NA,38.1,38.1,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2022,2022-01-01T00:00:00+01:00,2022-12-31T00:00:00+01:00,Timor-Leste,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
9989912,AMR_INFECT_MRSA,COUNTRY,KOR,WPR,YEAR,Western Pacific,NA,NA,2020,NA,NA,NA,NA,NA,NA,47.5,47.55,NA,NA,Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center,2025-05-07T13:40:20.167+02:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Republic of Korea,Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%),EN,NA
